Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4438 Rl-338
Novel potent and highly selective GPR6 inverse agonist, inhibiting GPR6 cAMP signalling in TR-FRET assays with a EC50 = 16 nM and >100 fold selectivity against GPR3 and GPR12
More description
DCC4437 Rkn5755
Novel selective inhibitor of activated fibroblasts, inhibiting the enhanced migration of fibroblasts cocultured with cancer cells by binding to β-arrestin1 and interfering with β-arrestin1-mediated cofilin signaling pathways
More description
DCC4436 Rk-9123016
Novel potent and selective SIRT2 inhibitor, increasing the acetylation level of eukaryotic translation initiation factor 5A (eIF5A) and reducing cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression
More description
DCC4435 Rk-682
Natural selective inhibitor of protein tyrosine phosphatases (PTPases)
More description
DCC4434 Rk-0404678
Novel inhibitor of dengue virus NS5 RNA-dependent RNA polymerase (RdRp), inhibiting the DENV type 2 (DENV2) RdRp activities
More description
DCC4433 Rjw100
Novel potent Liver Receptor Homolog-1 (LRH-1) modulator
More description
DCC4432 Rjr-2403 Fumarate
Highly selective α4β2 subtype nicotinic receptor agonist
More description
DCC4431 Rivoglitazone Hydrochloride
Novel peroxisome proliferator-activated receptor gamma (PPARgamma) agonist
More description
DCC4430 Ripk2 Protac 20
Novel IAP-based selective RIPK2 degrader
More description
DCC4429 Rip2-in-3
First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific inhibitor
More description
DCC4428 Rinoxiab
Natural inducer of apoptosis by significantly upregulating Bcl-2, mitigating expression of Bcl2 in HCT 15 cells and attenuating the apoptotic markers and cell cycle regulatory proteins
More description
DCC4427 R-imeglimin
Novel antidiabetic agent, impairing glucose uptake by muscle tissue, excessing hepatic gluconeogenesis, and increasing beta-cell apoptosis
More description
DCC4426 Rilpivirine Hydrochloride
HIV-1 reverse transcriptase inhibitor, also acting as an EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
More description
DCC4424 Rifamycin Sv
Natural antibiotic, inhibiting prokaryotic DNA-dependent RNA synthesis and protein synthesis; blocking RNA-polymerase transcription initiation, modulating ß2m aggregation
More description
DCC4423 Rifametane
Antibiotic for tuberculosis (TB) treatment
More description
DCC4422 Ricasetron
Selective antagonist of the serotonin 5-HT3 receptor
More description
DCC4421 Rhodblock 1a
Potent inhibitor of the Rho pathway
More description
DCC4420 rhm-138
Selective sigma-2 ligand, inducing apoptosis in EMT-6 breast cancer cells
More description
DCC4419 Rhlr Antagonist E22
Quorum sensing modulator as a RhlR antagonist
More description
DCC4418 Rhlr Antagonist 30
Novel potent and selective RhlR antagonist, strongly inhibiting biofilm formation, and reducing production of virulence factors in P. aeruginosa
More description
DCC4417 Rhlr Agonist S4
Quorum sensing modulator as a RhlR agonist
More description
DCC4416 Rhizoxin
Potent tubulin assembly and cancer cell growth inhibitor
More description
DCC4415 Rh-5849
Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi)
More description
DCC4414 Rh02007
Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein
More description
DCC4413 rh01617
Potent inhibitor of Kv1.5 potassium channel
More description
DCC4412 Rgia-5524
Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain
More description
DCC4411 rgh-237
Orally active, selective dopamine D3 receptor partial agonist
More description
DCC4410 Rgd-ss-ca
Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity
More description
DCC4409 Rgd-mimetic-1
Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6
More description
DCC4408 Rgb-286147
Potent, selective & ATP-competitive inhibitor of Cdks
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X